The UC Davis MIND Institute is a collaborative international research center, committed to the awareness, understanding, prevention, and treatment of the challenges associated with neurodevelopmental disabilities.
Join our Research Community
Participate in our studies to help Researchers better understand neurodevelopmental disabilities.
Advanced Knowledge
Browse through recent articles detailing findings from MIND Institute studies.
MIND Featured Study
Researchers at the UC Davis MIND Institute are studying an investigational drug, BPN14770 (zatolmilast), to see how it acts in the body, how well it works, and if it is safe in adolescent males aged 12 to <18 with fragile X syndrome.
Research Overview
The MIND Institute conducts collaborative multidisciplinary research on neurodevelopmental disabilities, including Autism, Down syndrome, Fragile X syndrome, Attention-Deficit/Hyperactivity Disorder (ADHD), and Chromosome 22q11.2 deletion syndrome.
The MIND Institute is uniquely positioned to take advantage of the outstanding expertise at UC Davis. The university offers robust programs in biological, environmental, medical and toxicological sciences.
The scope and impact of the MIND Institute’s research program is broad. Studies ranging from basic biological research to clinical treatment trials have led to new understanding of genetic and environmental causes of neurodevelopmental disabilities, identification of differences in brain structure and function, groundbreaking interventions, and advances in very early diagnosis.
RESEARCH CLINIC SICK POLICY
The MIND Institute values the health and safety of its patients, research participants, employees, students, and visitors. We ask that if you have an appointment and are experiencing flu like symptoms or other infectious symptoms, please call ahead before visiting the MIND Institute. You may be asked to reschedule your appointment. Our staff will implement these safeguards as conditions warrant. We appreciate your understanding.